← Back

Bluestar Adisseo Co

Bluestar Adisseo Company, together with its subsidiaries, researches, develops, produces, and sells nutrition additives for poultry, ruminant, swine, and aquaculture. It also offers mycotoxin management and palatability products, enzymes and emulsifiers, antioxidants and health by nutrition products, milk production products, and sulfur-based products. The company provides services including PNE, MYCOMAN, ADICT, Predictor, E.lab, DIM, MilkPay calculator, Milk$MART, and NESTOR. Founded in 1939 and based in Beijing, China, it operates in China, Europe, the Middle East, Africa, the Indian subcontinent, North and South America, and the Asia-Pacific. It is a subsidiary of China National Bluestar (Group) Co, Ltd.

Country
Price · split & dividend adjusted
News & notes moving 600299.CG
600299.CG▲

Adisseo's 2026 interim net profit reaches 905 million yuan, up 22.25% year on year

Adisseo has released its 2026 interim report. Total operating revenue was 9.707 billion yuan, up 14.04% year on year, and net profit attributable to the parent company was 905 million yuan, up 22.25% year on year, marking three consecutive years of growth for both. Net cash inflow from operating activities was 1.2 billion yuan, the asset-liability ratio was 30.83%, gross margin was 28.38%, return on equity was 4.59%, and diluted earnings per share were 0.29 yuan. The company had 27,800 shareholders, and the top ten shareholders held 80.44% of the shares.
600299.CG ▲
Jiemian·19dRead more →
600299.CG▼

Adisseo Deputy General Manager Wang Yan Receives Prior Notice of Administrative Penalty from CSRC

Adisseo announced that its deputy general manager Wang Yan recently received a Prior Notice of Administrative Penalty issued by the Liaoning Regulatory Bureau of the China Securities Regulatory Commission. The notice stems from matters related to another company where he previously worked, does not involve Adisseo, and will not have a material adverse impact on the company's daily production and operations. As of the disclosure date of the announcement, Wang Yan has not been subjected to any market ban measures, nor has he been publicly identified by a stock exchange as unfit to serve as a director or senior executive of a listed company.
600299.CG ▼
南方财经网·32dRead more →
© 2026 MarketDXAsset